Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes
Diabetes Research and Clinical Practice Mar 12, 2018
Osaka T, et al. - This research incorporated an examination of the link between the creatinine/cystatin (Cre/CysC) ratio and sarcopenia in subjects with type 2 diabetes. Based on the results, it was inferred that the Cre/CysC ratio was related to an increased risk of sarcopenia. Therefore, the Cre/CysC ratio was suggested as a practical screening marker for sarcopenia in the study cohort.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
